CoQ10

Coenzyme Q10 (CoQ10) is a naturally occurring, fat-soluble compound found in every cell of the human body. It plays a central role in the electron transport chain within mitochondria, where it facilitates the conversion of energy from food into adenosine triphosphate (ATP) — the primary energy currency of cells. CoQ10 also acts as a membrane-bound antioxidant, protecting lipids and proteins from oxidative damage.

Brands use CoQ10 in gummy supplements to target energy metabolism, cardiovascular health, and healthy ageing. It is one of the most familiar and commercially understood gummy actives across EU and US markets. While CoQ10 has no authorised health claims under EU Regulation 432/2012, its strong consumer awareness and well-documented mechanistic profile make it a high-value ingredient for premium positioning.

Origin and history

CoQ10 was first isolated from beef heart mitochondria by Dr. Frederick Crane and colleagues at the University of Wisconsin in 1957. Its chemical structure was elucidated the following year by Dr. Karl Folkers, who later synthesised the compound. The "Q" in CoQ10 refers to the quinone chemical group, and the "10" denotes the number of isoprenyl units in its side chain.

Industrial production of CoQ10 has evolved from extraction of animal tissues to fermentation using yeast and bacteria. Today, most commercial CoQ10 is produced via fermentation of the bacterium *Agrobacterium tumefaciens* or yeast strains, with Kaneka Corporation being the dominant global supplier. The fermentation process yields high-purity CoQ10 suitable for food supplement applications, including gummy manufacturing.

Scientific overview

CoQ10 exists in two interconvertible forms in the body: ubiquinone (the oxidised form) and ubiquinol (the reduced, antioxidant-active form). In the inner mitochondrial membrane, ubiquinone accepts electrons from complexes I and II of the electron transport chain and transfers them to complex III, driving ATP synthesis. Simultaneously, ubiquinol neutralises lipid peroxyl radicals, preventing oxidative damage to mitochondrial and cellular membranes.

Bioavailability of CoQ10 is limited by its high molecular weight and lipophilic nature. Absorption is enhanced when CoQ10 is taken with dietary fat or formulated with solubilisation technologies such as lipid-based delivery systems, micellisation, or nanoparticle formulations. The reduced form, ubiquinol, is more bioavailable than ubiquinone at equivalent doses, though both forms are used in supplements.

From a manufacturing perspective, CoQ10 is heat-stable and can be incorporated into gummy formulations without significant degradation. It is tasteless at typical use levels, which simplifies flavour masking. The primary manufacturing watchpoint is payload capacity — CoQ10 is a dense powder, and achieving doses above 100 mg per gummy may require larger gummy weights or multiple gummies per serving. DAT reviews payload constraints per project.

CoQ10 occupies a well-established position in the supplement market, particularly for energy, heart health, and healthy ageing. Consumer awareness is high, and the ingredient benefits from decades of clinical research. Gummy formats offer a convenient, palatable delivery system for CoQ10, especially for consumers who struggle with swallowing capsules or tablets. The fat-soluble nature of CoQ10 aligns well with gummy formulations, which can incorporate oils and emulsifiers to enhance absorption.

From a formulation and manufacturing standpoint, CoQ10 is one of the more straightforward premium ingredients to work with in gummies. It is heat-stable, tasteless, and compatible with standard gummy processing conditions. The main tradeoff is cost — CoQ10 is a premium ingredient, and achieving clinically relevant doses (typically 100 mg–200 mg per serving) increases per-unit cost. Brands should also consider that CoQ10 is not vegan-suitable in most supply chains, which may limit positioning in plant-based ranges.

For pack copy, brands should avoid disease claims and the term "anti-inflammatory" in EU markets. Since CoQ10 has no authorised health claims under Reg. 432/2012, positioning should focus on general wellness language such as "supports cellular energy production" or "contributes to normal heart function" — noting that the latter is a structure-function claim, not an authorised health claim. Co-formulating with Selenium (authorised claim: "contributes to the protection of cells from oxidative stress") or Magnesium (authorised claim: "contributes to normal energy-yielding metabolism") can provide claim coverage. DAT reviews all claim wording per project to ensure compliance.